Mortality from Listeria monocytogenes meningoencephalitis following escalation to alemtuzumab therapy for relapsing-remitting Multiple Sclerosis von Canham, L.J.W., Manara, A., Fawcett, J., Rolinski, M., Mortimer, A., Inglis, K.E.A., Cottrell, D.A.

Volltext